AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day

Old National Bancorp

Change company Symbol lookup

Select an option...

ONB Old National Bancorp

TIG Trean Insurance Group Inc

NVDA NVIDIA Corp

DICE Dice Therapeutics Inc

NUSI Nationwide Nasdaq-100® Risk-Managed Income ETF

TISI Team Inc

UIHC United Insurance Holdings Corp

BFI Burgerfi International Inc

COW iPath? Series B Bloomberg Livestock Subindex Total Return ETN

PYXS Pyxis Oncology Inc

Financials : Banks | Small Cap Value

Company profile

Old National Bancorp is a financial holding company. The Company, through its wholly owned banking subsidiary, Old National Bank, provides a range of services, including commercial and consumer loan and depository services, private banking, brokerage, trust, investment advisory, and other banking services. Its banking centers focuses on providing a group of community banking services. It provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions for businesses. Its loans consist primarily of loans made to consumers and commercial clients in various industries, including real estate rental and leasing, manufacturing, wholesale trade, construction, and agriculture, among others. In addition to providing lending and deposit services, it offers wealth management, investment, and foreign currency services. Its banking centers are in Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, and Wisconsin.

AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day

4:33 pm ET January 5, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) sank 0.12% to $163.49 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.16% to 3,808.10 and Dow Jones Industrial Average falling 1.02% to 32,930.08. The stock's fall snapped a two-day winning streak. AbbVie Inc. closed $12.42 short of its 52-week high ($175.91), which the company achieved on April 8th.

Despite its losses, the stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.74% to $178.80 and Pfizer Inc. (PFE) fell 0.94% to $49.66. Trading volume (3.5 M) remained 1.9 million below its 50-day average volume of 5.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 5, 2023.

(END) Dow Jones Newswires

January 05, 2023 16:33 ET (21:33 GMT)

Postmarket

Change Since Close

Market Hours

AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day